• Pulmonary Structural Changes Regulate Lung Bacteria in COPD Patients, Study Finds
  • Sunovion Divesting U.S. Market Rights to Asthma and Allergic Rhinitis Therapies to Covis Pharma
  • Cytokinetics Launches Phase 1b Trial for COPD Therapy Candidate CK-2127107
  • Positive Airway Pressure Therapy Might Reduce COPD Hospitalizations, But Few Patients Receive It
  • FDA Agrees to New Review of the SUN-101/e-Flow COPD Treatment System
  • Verona Gets Green Light to Enroll Patients in European Trial of COPD Therapy RPL554
  • UK’s National Health Service Approves Daxas as Treatment for COPD
  • $10M NIH Grant Aims to Identify Genes Linked to COPD, Other Diseases
  • Tilray Announces Support for Clinical Trial Evaluating Medical Cannabis Efficacy in COPD Patients
  • Pulmatrix Licenses RespiVert’s Kinase Inhibitor Therapies for COPD and Other Lung Diseases
  • BCBSTX to Invest $10 Million in COPD and Chronic Diabetic Kidney Disease Prevention in Texas
  • Verona Pharma Announces New Clinical Trial for Inhaled Lung Therapy RPL554